Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy

Cancer Cell

Volumn 7, Issue 3, 2005, Pages 227-238

  Tan, Ting Ting ^b,d   Degenhardt, Kurt ^b,c,d   Nelson, Deirdre A ^a   Beaudoin, Brian ^b   Nieves Neira, Wilberto ^e   Bouillet, Philippe ^f   Villunger, Andreas ^f,g   Adams, Jerry M ^f   White, Eileen ^a,b,c,d,e  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b Ctr for Adv Biotech and Medicine   (United States)

^c Dept of Molec Biol and Biochem ^*  (United States)

^d RUTGERS UNIVERSITY   (United States)

^e RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^f WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BH3 PROTEIN; BIM PROTEIN; BORTEZOMIB; CYCLOHEXIMIDE; EPOXOMICIN; ETOPOSIDE; MITOGEN ACTIVATED PROTEIN KINASE; P 341; PACLITAXEL; PROTEASOME; PROTEASOME INHIBITOR; RAS PROTEIN; THAPSIGARGIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SENSITIVITY; EPITHELIUM TUMOR; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SOLID TUMOR;

EID: 17644421083     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.02.008     Document Type: Article

References (50)

1. J. Adams Potential for proteasome inhibition in the treatment of cancer Drug Discov. Today 8 2003 307 315
2. J.M. Adams Ways of dying: Multiple pathways to apoptosis Genes Dev. 17 2003 2481 2495
3. J. Adams, and M. Kauffman Development of the proteasome inhibitor Velcade (Bortezomib) Cancer Invest. 22 2004 304 311
4. T. Akiyama, P. Bouillet, T. Miyazaki, Y. Kadono, H. Chikuda, U.-I. Chung, A. Fukuda, A. Hikita, H. Seto, and T. Okada Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim EMBO J. 22 2003 6653 6664
5. J. An, Y. Sun, M. Fisher, and M.B. Rettig Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-κB dependent Mol. Cancer Ther. 3 2004 727 736
6. K.N. Bhalla Microtubule-targeted anticancer agents and apoptosis Oncogene 22 2003 9075 9086
7. P. Bouillet, D. Metcalf, D.C.S. Huang, D.M. Tarlinton, T.W.H. Kay, F. Kontgen, J.M. Adams, and A. Strasser Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity Science 286 1999 1735 1738
8. P. Bouillet, S. Cory, L.C. Zhang, A. Strasser, and J.M. Adams Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim Dev. Cell 1 2001 645 653
9. P. Bouillet, J.F. Purton, D.I. Godfrey, L.-C. Zhang, L. Coultas, H. Puthalakath, M. Pellegrini, S. Cory, J.M. Adams, and A. Strasser BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes Nature 415 2002 922 926
10. L sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis Mol. Cell 8 2001 705 711
11. S. Cory, and J.M. Adams The Bcl2 family: Regulators of the cellular life-or-death switch Nat. Rev. Cancer 2 2002 647 656
12. S. Cory, D.C.S. Huang, and J.M. Adams The Bcl2-2 family: Roles in cell survival and oncogene Oncogene 22 2003 8590 8607
13. A. Cuconati, C. Mukherjee, D. Perez, and E. White DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells Genes Dev. 23 2003 2922 2932
14. K. Degenhardt, G. Chen, T. Lindsten, and E. White Bax and Bak mediate p53-independent suppression of tumorigenesis Cancer Cell 2 2002 193 203
15. K. Degenhardt, R. Sundararajan, T. Lindsten, C.B. Thompson, and E. White Bax and Bak independently promote cytochrome-c release from mitochondria J. Biol. Chem. 277 2002 14127 14134
16. S. Dimmeler, K. Breitschopf, J. Haendeler, and A.M. Zeiher Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: A link between the apoptosome and the proteasome pathway J. Exp. Med. 189 1999 1815 1822
17. J. Downward Targeting RAS signalling pathways in cancer therapy Nat. Rev. Cancer 3 2003 11 22
18. A. Egle, A.W. Harris, P. Bouillet, and S. Cory Bim is a suppressor of Myc-induced mouse B cell leukemia Proc. Natl. Acad. Sci. USA 101 2004 6164 6169
19. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
20. M.T. Hemann, J.T. Zilfou, Z. Zhao, D.J. Burgess, G.J. Hannon, and S.W. Lowe Suppression of tumorigenesis by the p53 target PUMA Proc. Natl. Acad. Sci. USA 101 2004 9333 9338
21. R.W. Johnstone, A.A. Ruefli, and S.W. Lowe A link between cancer genetics and chemotherapy Cell 108 2002 153 164
22. M. Jost, T.M. Huggett, C. Kari, L.H. Boise, and U. Rodeck Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway J. Biol. Chem. 276 2001 6320 6326
23. C.M. Leu, C. Chang, and C. Hu Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway Oncogene 19 2000 1665 1675
24. R. Ley, K. Balmanno, K. Hadfield, C. Weston, and S.J. Cook Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim J. Biol. Chem. 278 2003 18811 18816
25. R. Ley, K.E. Ewings, K. Hadfield, E. Howes, K. Balmanno, and S.J. Cook Extracellular signal-regulated kinases 1/2 are serum-stimulated "Bim(EL) kinases" that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover J. Biol. Chem. 279 2004 8837 8847
26. H.-J. Lin, V. Eviner, G.C. Prendergast, and E. White Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest Mol. Cell. Biol. 15 1995 4536 4544
27. Y.Z. Liu, L.M. Boxer, and D.S. Latchman Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade Nucleic Acids Res. 27 1999 2086 2090
28. F. Luciano, A. Jacquel, P. Colosetti, M. Herrant, S. Cagnol, G. Pages, and P. Auberger Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function Oncogene 22 2003 6785 6793
29. J.P. MacKeigan, T.S. Collins, and J.P.-Y. Ting MEK inhibition enhances paclitaxel-induced tumor apoptosis J. Biol. Chem. 275 2000 38953 38956
30. M. Marani, D. Hancock, R. Lopes, T. Tenev, J. Downward, and N.R. Lemoine Role of Bim in the survival pathway induced by Raf in epithelial cells Oncogene 23 2004 2431 2441
31. H.M. McDaid, and S.B. Horwitz Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines Mol. Pharmacol. 60 2001 290 301
32. S.T. Nawrocki, B. Sweeney-Gotsch, R. Takamori, and D.J. McConkey The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts Mol. Cancer Ther. 3 2004 59 70
33. D.A. Nelson, T.-T. Tan, A. Rabson, D. Anderson, K. Degenhardt, and E. White Hypoxia and defective apoptosis drive genomic instability and tumorigenesis Genes Dev. 18 2004 2095 2107
34. L. O'Connor, A. Strasser, L.A. O'Reilly, G. Hausmann, J.M. Adams, S. Cory, and D.C.S. Huang Bim: A novel member of the Bcl-2 family that promotes apoptosis EMBO J. 17 1998 384 395
35. J.T. Opferman, A. Letai, C. Beard, M.D. Sorcinelli, C.C. Ong, and S.J. Korsmeyer Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1 Nature 426 2003 671 676
36. D.R. Plas, S. Talapatra, A.L. Edinger, J.C. Rathmell, and C.B. Thompson Akt and Bcl-xL Promote Growth Factor-independent Survival through Distinct Effects on Mitochondrial Physiology J. Biol. Chem. 276 2001 12041 12048
37. G.V. Putcha, S. Le, S. Frank, C.G. Besirli, K. Clark, B. Chu, S. Alix, R.J. Youle, A. LaMarche, A.C. Maroney, and E.M. Johnson JNK-mediated Bim phosphorylation potentiates Bax-dependent apoptosis Neuron 38 2003 899 914
38. H. Puthalakath, D.C.S. Huang, L.A. O'Reilly, S.M. King, and A. Strasser The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex Mol. Cell 3 1999 287 296
39. A.M. Ranger, J.P. Zha, H. Harada, S.R. Datta, N.N. Danial, A.P. Gilmore, J.L. Kutok, M.M. Le Beau, M.E. Greenberg, and S.J. Korsmeyer Bad-deficient mice develop diffuse large B cell lymphoma Proc. Natl. Acad. Sci. USA 100 2003 9324 9329
40. R. Ravi, and A. Bedi NF-κB in cancer-a friend turned foe Drug Resist. Updat. 7 2004 53 67
41. C. Reimertz, D. Kogel, A. Rami, T. Chittenden, and J.H. Prehn Gene expression during ER stress-induced apoptosis in neurons: Induction of the BH3-only protein Bbc3/PUMA and activation of the mitochondrial apoptosis pathway J. Cell Biol. 162 2003 587 597
42. A. Sunters, S. Fernandez de Mattos, M. Stahl, J.J. Brosens, G. Zoumpoulidou, C.A. Saunders, P.J. Coffer, R.H. Medema, R.C. Coombes, and E.W.-F. Lam FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines J. Biol. Chem. 278 2003 49795 49805
43. B.A. Teicher, G. Ara, R. Herbst, V.J. Palombella, and J. Adams The proteasome inhibitor PS-341 in cancer therapy Clin. Cancer Res. 5 1999 2638 2645
44. A. Villunger, E.M. Michalak, L. Coultas, F. Mullauer, G. Bock, M.J. Ausserlechner, J.M. Adams, and A. Strasser p53- and Drug-induced apoptotic responses mediated by BH3-only proteins PUMA and NOXA Science 302 2003 1036 1038
45. M.C. Wei, W.X. Zong, E.H.-Y. Cheng, T. Lindsten, V. Panoutsakopoulou, A.J. Ross, K.A. Roth, G.R. MacGregor, C.B. Thompson, and S.J. Korsmeyer Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death Science 292 2001 727 730
46. J. Wilson-Annan, L.A. O'Reilly, S.A. Crawford, G. Hausmann, J.C. Beaumont, L.P. Parma, L. Chen, M. Lackmann, T. Lithgow, and M.G. Hinds Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity J. Cell Biol. 162 2003 877 887
47. H. Yamaguchi, and H.-G. Wang Bcl-XL protects BimEL-induced Bax conformational change and cytochrome c release independent of interacting with Bax or BimEL J. Biol. Chem. 277 2002 41604 41612
48. Y. Zhu, B.J. Swanson, M. Wang, D.A. Hildeman, B.C. Schaefer, X. Liu, H. Suzuki, K. Mihara, J. Kappler, and P. Marrack Constitutive association of the proapoptotic protein Bim with Bcl-2-related proteins on mitochondria in T cells Proc. Natl. Acad. Sci. USA 101 2004 7681 7686
49. S.S. Zinkel, C.C. Ong, D.O. Ferguson, H. Iwasaki, K. Akashi, R.T. Bronson, J.L. Kutok, F.W. Alt, and S.J. Korsmeyer Proapoptotic BID is required for myeloid homeostasis and tumor suppression Genes Dev. 17 2003 229 239
50. W.-X. Zong, T. Lindsten, A.J. Ross, G.R. MacGregor, and C.B. Thompson BH3-only proteins that bind pro-survival BCL-2 family members fail to induce apoptosis in the absence of BAX and BAK Genes Dev. 15 2001 1481 1486